• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Other News

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

China NMPA Released: Common Q&A For Medical Device Registrations In 2023

2024-02-08

China NMPA has recently unveiled a comprehensive set of 71 Q&A addressing common issues encountered in the medical…

China National Healthcare Security Administration Office Issues Notice On The Release Of Medical Centralized Procurement Platform Service Standards (Version 1.0)

2024-02-01

In line with the directives of the Central Committee and the State Council, and in accordance with the…

NMPA New Approvals In December2023

2024-01-23

In December 2023, NMPA approved 343 medical devices, including 37 Class III imported products, 38 Class II imported…

Approval Granted For Stomach Bypass Stent System To Hit The Market

2024-01-23

On January 17th, the NMPA approved the innovative product registration application for the Stomach Bypass Stent System The…

China NMPA Newsletter – December 2023

2024-01-20

China NMPA Newsletter   Featured Articles NMPA New Approvals in November 2023 In November 2023, NMPA approved 301…

China And Denmark Strengthen Comprehensive Strategic Partnership With “Green Joint Action Plan”

2024-01-10

Background: Recognizing the mutual benefits of collaboration on bilateral, multilateral, and global issues, the People's Republic of China…

China NMPA Newsletter – November 2023

2023-12-31

Featured Articles NMPA New Approvals in November 2023 In November 2023, NMPA approved 301 medical devices, including 34…

NMPA New Approvals In November2023

2023-12-28

In November 2023, NMPA approved 301 medical devices, including 34 Class III imported products, 39 Class II imported…

China NMPA Reports 6 Cases Of Illegal Online Sales Of Medical Devices

2023-12-08

On December 5th , the National Medical Products Administration (NMPA) has guided local drug regulatory authorities to intensify…

NMPA New Approvals In October2023

2023-12-08

In October 2023, NMPA approved 221 medical devices, including 28 Class III imported products, 16 Class II imported…

NMPA Upgrades Regulatory Classification Of Degradable Expandable Hemostatic Sponge Products

2023-12-07

NMPA released information on December 4th to upgrade the classification of Degradable Expandable Hemostatic Sponge Products from Class…

China Approves Innovative Single-Port Laparoscopic Surgery System

2023-12-04

On November 24, 2023, the NMPA granted approval for the innovative "Single-Incision Laparoscopic Surgery System. The system comprises…
Prev12345...81012...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7